The active cases comprise 0.03 per cent of the total infections, while the national Covid-19 recovery rate remained at 98.76 per cent, the ministry said
India has so far administered 1,867,215,865 vaccine doses. That is 4337.32 per cent of its total caseload, and 133.12 per cent of its population
The global coronavirus caseload has topped 505.8 million, while the deaths have surged to more than 6.20 million and vaccinations to over 11.19 billion, according to Johns Hopkins University
Spike in Delhi Covid cases deserves attention
The death toll climbed to 5,21,965 with 214 fresh fatalities, the data updated at 8 am stated
Three new deaths from Covid-19 were reported on Sunday in Shanghai, according to the report
The municipal health commission said on Sunday said that Shanghai has reported 3,238 confirmed locally transmitted COVID-19 cases in the last 24 hours
Despite less number of tests, the positivity rate jumped high and went beyond 5 per cent on Saturday
After a decline, the Covid infection rate is again showing an upward trend in Noida and the number of active cases has crossed the 150 mark
India has so far administered 1,863,062,546 vaccine doses. That is 4328.67 per cent of its total caseload, and 132.82 per cent of its population
On Monday, the positivity rate was 2.7 per cent -- the highest in two months. It was 2.87 per cent on February 5
The state is now left with 162 active cases, the official said
Chennai added eight new cases, the maximum among the districts while 28 of them (total 38) reported zero new cases today
India has so far administered 1,862,276,304 vaccine doses. That is 4326.94 per cent of its total caseload, and 132.76 per cent of its population
Centre may have to step in to ensure universal coverage, some say; also call for shift in focus to strengthen surveillance, testing and gathering data
Private channel alone will not be enough
No fresh fatality occurred today and the death toll continued to be 4,111
Daily cases count in Delhi is being reported in range of 100-200, we are keeping an eye on hospital admissions, and that is going down. Focus shouldn't be on positivity rate much as of now, Jain said
Indian biopharma company to initiate Phase-I and Phase-II trials, plans fundraise of Rs 200 crore of funding for third phase of trials
According to study in 'Chemosphere' published by SAFAR, experts say that biomass emissions of carbon rich tiny particles and rapid flow of distant dust were found to be primary reasons for pollution